{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T23:16:51Z","timestamp":1788045411437,"version":"build-2784847793"},"reference-count":76,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1097\/bor.0b013e32834aa45f","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T19:53:22Z","timestamp":1317758002000},"page":"519-529","source":"Crossref","is-referenced-by-count":18,"title":["Hematopoietic stem cell transplantation for systemic sclerosis"],"prefix":"10.1097","volume":"23","author":[{"given":"Richard K.","family":"Burt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Milanetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210128","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"R2-4-20210128","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.amjmed.2004.04.031","article-title":"Mortality in systemic sclerosis: an international meta-analysis of individual patient data.","volume":"118","author":"Ioannidis","year":"2005","journal-title":"Am J Med"},{"key":"R3-4-20210128","first-page":"139","article-title":"Systemic sclerosis: demographic, clinical, and serologic features and survival in 1012 Italian patients.","volume":"81","author":"Ferri","year":"2002","journal-title":"Medicine(Baltimore)"},{"key":"R4-4-20210128","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00005792-200203000-00005","article-title":"Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival.","volume":"81","author":"Scussel-Lonzetti","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"R5-4-20210128","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1002\/1529-0131(199912)42:12<2660::AID-ANR23>3.0.CO;2-N","article-title":"Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit.","volume":"42","author":"Bryan","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R6-4-20210128","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2796.1993.tb00753.x","article-title":"Survival analysis of 118 patients with systemic sclerosis.","volume":"234","author":"Czirjak","year":"1993","journal-title":"J Intern Med"},{"key":"R7-4-20210128","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/BF02238937","article-title":"Predictors of survival in 171 patients with systemic sclerosis (scleroderma).","volume":"16","author":"Nagy","year":"1997","journal-title":"Clin Rheumatol"},{"key":"R8-4-20210128","first-page":"165","article-title":"Increased C reactive protein and aminoterminal propeptide of type III procollagen levels are unfavourable predictors of survival in systemic sclerosis (scleroderma).","volume":"23","author":"Nagy","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"R9-4-20210128","first-page":"2454","article-title":"Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.","volume":"28","author":"Jacobsen","year":"2001","journal-title":"J Rheumatol"},{"key":"R10-4-20210128","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/ard.57.11.682","article-title":"Mortality and causes of death in a Swedish series of systemic sclerosis patients.","volume":"57","author":"Hesselstrand","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"R11-4-20210128","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/rheumatology\/37.7.750","article-title":"Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma).","volume":"37","author":"Jacobsen","year":"1998","journal-title":"Br J Rheumatol"},{"key":"R12-4-20210128","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.semarthrit.2008.06.002","article-title":"Determinants of morbidity and mortality of systemic sclerosis in Canada.","volume":"39","author":"Al-Dhaher","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"R13-4-20210128","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/ard.2006.066340","article-title":"Survival and causes of death in 366 Hungarian patients with systemic sclerosis.","volume":"67","author":"Czirjak","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R14-4-20210128","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0002-8703(85)90525-3","article-title":"Prediction of survival in progressive systemic sclerosis by multivariate analysis of clinical features.","volume":"110","author":"Wynn","year":"1985","journal-title":"Am Heart J"},{"key":"R15-4-20210128","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0895-4356(88)90094-7","article-title":"Retrospective studies in scleroderma: effect of potassium para-aminobenzoate on survival.","volume":"41","author":"Zarafonetis","year":"1988","journal-title":"J Clin Epidemiol"},{"key":"R16-4-20210128","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0021-9681(73)90054-4","article-title":"Survival with scleroderma II. A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patients.","volume":"26","author":"Medsger","year":"1973","journal-title":"J Chron Dis"},{"key":"R17-4-20210128","first-page":"71","article-title":"Mortality and prognostic factors in Spanish patients with systemic sclerosis.","volume":"42","author":"Simeon","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"R18-4-20210128","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","article-title":"Severe organ involvement in systemic sclerosis with diffuse scleroderma.","volume":"43","author":"Steen","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R19-4-20210128","doi-asserted-by":"crossref","first-page":"602","DOI":"10.7326\/0003-4819-118-8-199304150-00005","article-title":"Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis).","volume":"118","author":"Bulpitt","year":"1993","journal-title":"Ann Intern Med"},{"key":"R20-4-20210128","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1161\/01.CIR.21.6.1088","article-title":"Prognostic significance of Raynauds phenomenon and other clinical characteristics of systemic scleroderma.","volume":"21","author":"Farmer","year":"1960","journal-title":"Circulation"},{"key":"R21-4-20210128","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1136\/ard.60.12.1117","article-title":"Disease severity of 100 patients with systemic sclerosis over a period of 14 years: using a modified Medsger scale.","volume":"60","author":"Geirsson","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"R22-4-20210128","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/1529-0131(200011)43:11<2445::AID-ANR11>3.0.CO;2-Q","article-title":"Skin thickness score as a predictor and correlate of outcome in systemic sclerosis.","volume":"43","author":"Clements","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R23-4-20210128","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/000155599750010986","article-title":"Serum levels of soluble TNF alpha receptor type I and the severity of systemic sclerosis.","volume":"79","author":"Majewski","year":"1999","journal-title":"Acta Derm Venereol"},{"key":"R24-4-20210128","first-page":"911","article-title":"Different antibody patterns and different prognosis in patients with scleroderma with various extent of skin sclerosis.","volume":"13","author":"Giordano","year":"1986","journal-title":"J Rheumatol"},{"key":"R25-4-20210128","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/BF00371817","article-title":"Epidemiological study of patients with systemic sclerosis in Tokyo.","volume":"283","author":"Tamaki","year":"1991","journal-title":"Arch Dermatol Res"},{"key":"R26-4-20210128","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1002\/art.22721","article-title":"Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis. Application of a latent linear trajectory model.","volume":"56","author":"Shand","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R27-4-20210128","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1002\/1529-0131(200112)44:12<2828::AID-ART470>3.0.CO;2-U","article-title":"Improvement in skin thickening in systemic sclerosis associated with improved survival.","volume":"44","author":"Steen","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R28-4-20210128","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/art.24525","article-title":"The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France.","volume":"60","author":"Hachulla","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R30-4-20210128","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R32-4-20210128","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/157488811794480663","article-title":"Autologous hematopoietic stem cell transplantation for systemic sclerosis.","volume":"6","author":"Milanetti","year":"2011","journal-title":"Curr Stem Cell Res Ther"},{"key":"R33-4-20210128","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/ard.60.6.592","article-title":"European multicentre study to define disease activity criteria for systemic sclerosis II. Identification of disease activity variables and development of preliminary activity indices.","volume":"60","author":"Valentini","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"R34-4-20210128","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/1529-0131(200106)44:6<1351::AID-ART227>3.0.CO;2-I","article-title":"A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma.","volume":"44","author":"Pope","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R35-4-20210128","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/rheumatology\/35.4.364","article-title":"Comparison of methotrexate with placebo in the treatment of systemic sclerosis: a 24-week randomized double-blind trial, followed by a 24-week observational trial.","volume":"35","author":"Van den Hoogen","year":"1996","journal-title":"Br J Rheumatol"},{"key":"R36-4-20210128","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/1529-0131(199906)42:6<1194::AID-ANR16>3.0.CO;2-7","article-title":"High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial.","volume":"42","author":"Clements","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R37-4-20210128","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/rheumatology\/kep093","article-title":"Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study.","volume":"49","author":"Daoussis","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"R38-4-20210128","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O","article-title":"Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis.","volume":"41","author":"Steen","year":"1998","journal-title":"Arthritis Rheum"},{"key":"R39-4-20210128","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/art.1780360113","article-title":"Cyclosporin (CsA) in systemic sclerosis (SSc): results of a 48-week open safety study in 10 SSc patients.","volume":"36","author":"Clements","year":"1993","journal-title":"Arthritis Rheum"},{"key":"R40-4-20210128","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease.","volume":"354","author":"Tashkin","year":"2006","journal-title":"N Engl J Med"},{"key":"R41-4-20210128","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1164\/rccm.200702-326OC","article-title":"Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.","volume":"176","author":"Tashkin","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"R42-4-20210128","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10067-005-1157-y","article-title":"A randomized unblinded trial of cyclophosphamide versus azathioprine in the treatment of systemic sclerosis.","volume":"25","author":"Nadashkevich","year":"2006","journal-title":"Clin Rheumatol"},{"key":"R43-4-20210128","doi-asserted-by":"crossref","first-page":"R124","DOI":"10.1186\/ar2534","article-title":"Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies.","volume":"10","author":"Nannini","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"R44-4-20210128","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar2634","article-title":"High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy.","volume":"11","author":"Hunzelmann","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"R45-4-20210128","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/art.21714","article-title":"Scleroderma treatment differs between experts and general rheumatologists.","volume":"55","author":"Pope","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R46-4-20210128","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1600-0609.2005.00569.x","article-title":"Infections after CD34-selected or unmanipulated autologous hematopoietic stem cell transplantation.","volume":"76","author":"Frere","year":"2006","journal-title":"Eur J Haematol"},{"key":"R47-4-20210128","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1399-3062.2009.00401.x","article-title":"Infectious complications in patients receiving autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases.","volume":"11","author":"Kohno","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"R48-4-20210128","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1146\/annurev.immunol.21.120601.141110","article-title":"T cell anergy.","volume":"21","author":"Schwartz","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"R49-4-20210128","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/jama.299.8.925","article-title":"J. Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases.","volume":"299","author":"Burt","year":"2008","journal-title":"JAMA"},{"key":"R50-4-20210128","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20041679","article-title":"Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients.","volume":"201","author":"Muraro","year":"2005","journal-title":"J Exp Med"},{"key":"R51-4-20210128","doi-asserted-by":"crossref","first-page":"6346","DOI":"10.4049\/jimmunol.0901773","article-title":"Regulatory T cell (TReg) subsets return in patients with refractory lupus following adult stem cell transplantation: TGF-b producing CD81 Treg (CD8TGF-b Treg) are associated with suppressing lupus into immunologic remission.","volume":"183","author":"Zhang","year":"2009","journal-title":"J immunol"},{"key":"R52-4-20210128","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1182\/blood-2008-07-168286","article-title":"Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system.","volume":"113","author":"Alexander","year":"2009","journal-title":"Blood"},{"key":"R53-4-20210128","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/rheumatology\/keq414","article-title":"Analysis of immune reconstitution after autologous CD34 stemprogenitor cell transplantation for systemic sclerosis: predominant reconstitution of Th1 CD4 T cells.","volume":"50","author":"Tsukamoto","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"R54-4-20210128","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.3899\/jrheum.081025","article-title":"Immunological reconstitution after autologous hematopoietic stem cell transplantation in patients with systemic sclerosis: relationship between clinical benefits and intensity of immunosuppression.","volume":"36","author":"Bohgaki","year":"2009","journal-title":"J Rheumatol"},{"key":"R55-4-20210128","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.328.5980.825-e","article-title":"Risks of immune system treatments.","volume":"328","author":"Burt","year":"2010","journal-title":"Science"},{"key":"R56-4-20210128","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1002\/art.22256","article-title":"Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens.","volume":"54","author":"Burt","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R57-4-20210128","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1038\/sj.leu.2404850","article-title":"Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study.","volume":"21","author":"Montoto","year":"2007","journal-title":"Leukemia"},{"key":"R58-4-20210128","first-page":"683","article-title":"Chromosomal breakage in diffuse scleroderma. A study of 27 patients.","volume":"16","author":"Emerit","year":"1971","journal-title":"Europ J Clin Biol Res"},{"key":"R59-4-20210128","first-page":"300","article-title":"Chromosomal abnormalities in progressive systemic sclerosis (scleroderma) with consideration of radiation effects.","volume":"86","author":"Pan","year":"1975","journal-title":"J Lab Clin Med"},{"key":"R60-4-20210128","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/BF00283732","article-title":"Family studies in scleroderma (systemic sclerosis) demonstrating an HLA-linked increased chromosomal breakage rate in cultured lymphocytes.","volume":"81","author":"Rittner","year":"1988","journal-title":"Hum Genet"},{"key":"R61-4-20210128","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/mutage\/14.2.227","article-title":"Cytogenetic study and FISH analysis in lymphocytes of systemic lupus erythematosus and systemic sclerosis patients.","volume":"14","author":"Migliore","year":"1999","journal-title":"Mutagenesis"},{"key":"R62-4-20210128","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/rheumatology\/35.8.732","article-title":"Telomere reduction in scleroderma patients: a possible cause for chromosomal instability.","volume":"35","author":"Artlett","year":"1996","journal-title":"Br J Rheumatol"},{"key":"R63-4-20210128","first-page":"837","article-title":"Spontaneous and clastogen induced chromosomal breakage in scleroderma.","volume":"18","author":"Wolff","year":"1991","journal-title":"J Rheumatol"},{"key":"R64-4-20210128","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/ard.60.6.577","article-title":"Phase III trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease.","volume":"60","author":"Binks","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"R65-4-20210128","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1046\/j.1365-2141.2002.03895.x","article-title":"Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study.","volume":"119","author":"Farge","year":"2002","journal-title":"Br J Haematol"},{"key":"R66-4-20210128","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1182\/blood.V100.5.1602.h81702001602_1602_1610","article-title":"High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes.","volume":"100","author":"McSweeney","year":"2002","journal-title":"Blood"},{"key":"R67-4-20210128","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1182\/blood-2007-02-072389","article-title":"High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study.","volume":"110","author":"Nash","year":"2007","journal-title":"Blood"},{"key":"R68-4-20210128","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/ard.2003.011205","article-title":"Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMTEULAR Registry.","volume":"63","author":"Farge","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"R69-4-20210128","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/ard.2005.037879","article-title":"A phase I-II trial of autologous peripheral blood stem cell transplantation in the treatment of refractory autoimmune disease.","volume":"65","author":"Tsukamoto","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R70-4-20210128","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/sj.bmt.1705782","article-title":"Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis.","volume":"40","author":"Oyama","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"R71-4-20210128","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/ard.2007.071464","article-title":"Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis.","volume":"67","author":"Vonk","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R73-4-20210128","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1164\/rccm.200604-547OC","article-title":"Tricuspid annular displacement predicts survival in pulmonary hypertension.","volume":"174","author":"Forfia","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"R74-4-20210128","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1445-5994.2007.01593.x","article-title":"Autologous stem cell transplantation in diffuse scleroderma: impact on hand structure and function.","volume":"38","author":"Englert","year":"2008","journal-title":"Intern Med J"},{"key":"R75-4-20210128","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1600-0609.1990.tb00387.x","article-title":"Antilymphocyte immunoglobulins stimulate peripheral blood lymphocytes to proliferate and release lymphokines.","volume":"44","author":"Taniguchi","year":"1990","journal-title":"Eur J Haematol"},{"key":"R76-4-20210128","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/15476910801897433","article-title":"Monoclonal antibody first dose cytokine release syndromes-mechanisms and prediction.","volume":"5","author":"Wing","year":"2008","journal-title":"J Immunotoxicol"},{"key":"R78-4-20210128","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/rheumatology\/kel451","article-title":"Skin involvement in sclerodermawhere histological and clinical scores meet.","volume":"46","author":"Verrecchia","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"R79-4-20210128","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/ard.2007.082495","article-title":"Autologous stem cell transplantation improves microcirculation in systemic sclerosis.","volume":"68","author":"Miniati","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R80-4-20210128","doi-asserted-by":"crossref","first-page":"e1452","DOI":"10.1371\/journal.pone.0001452","article-title":"Capillary regeneration in scleroderma: stem cell therapy reverses phenotype PLoS","volume":"3","author":"Fleming","year":"2008","journal-title":"ONE"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0b013e32834aa45f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:27:12Z","timestamp":1786048032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002281-201111000-00004"}},"subtitle":["history and current status"],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":76,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e32834aa45f","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}